Tag: ER-positive breast cancer patients
Drug candidate offers hope for ER-positive breast cancer patients
An international research collaboration, spearheaded by Pfizer in partnership with Monash University and the Cancer Therapeutics Cooperative Research Centre in Australia, has identified a promising pre-clinical drug candidate with potential anti-tumour activity against Estrogen Receptor (ER) positive breast cancer.
Featured Article
What spending reveals about downstream consumer demand for manufactured goods
For manufacturers supplying consumer-facing markets, understanding demand conditions has become increasingly important in an environment shaped by cautious spending, rising costs and intense competition.
